CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV
November 22nd 2023Additional doses for the prophylaxis of respiratory syncytial virus will immediately be distributed to physicians and hospitals through commercial channels and the Vaccines for Children Program.
Read More
Expert Discusses Biosimiliars Influencing Pricing of Biologic Drugs
November 22nd 2023Denise Giambalvo, director of Member Engagement & Business Strategy at the Washington Health Alliance and recently led a biosimilars initiative for the coalition, discusses biosimilar influence of pricing for biologic drugs, trends to expect in 2024, and why education on biosimilars are important for patients, pharmacists, prescribers, and more
Watch
Oncology Pharmacists Play a Unique Role in Addressing SDOH in the Community Setting
November 21st 2023Pharmacists address aspects of patient care that are unique to the focus of the pharmacist, such as financial toxicity and data collection for components of social determinants of health (SDOH).
Watch
Expert: Working Together, Sharing Information Is Crucial to PBM Reform
November 21st 2023Cheryl Larson, president and CEO of the Midwest Business Group on Health, discussed the employers’ perspectives on pharmacy benefit manager (PBM) reform efforts and how they can dovetail with the concerns of pharmacies.
Watch
Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs
November 21st 2023Zavegepant (Zavzpret; Pfizer) is the first and only only CGRP receptor antagonist as a nasal spray for the acute treatment of migraine in adults with and without aura approved by the FDA.
Read More
Extended-Release Buprenorphine Found Well-Tolerated for Fentanyl Opioid Use Disorder
November 21st 2023Eligible individuals with opioid use disorder using fentanyl received a single 4 mg dose of transmucosal buprenorphine followed by the extended-release buprenorphine 300 mg injection after approximately 1 hour.
Read More
Pharmacists Play Key Role in Educating Patients About HIV Risk, Treatments
November 20th 2023In the second part of his interview with Pharmacy Times, PharmD, CSP, AAHIVP, a clinical pharmacist and subject matter expert with Shields Health Solutions, discussed pharmacists’ role in HIV education and management.
Watch